Cellular Pathology Referrals - Christie Pathology Partnership

The procurement process for Cellular Pathology Referrals, conducted by Gateshead Health NHS Foundation Trust, is a service acquisition falling under the category of medical laboratory services (CPV 85145000). The procurement takes place in the UK, specifically at Queen Elizabeth Hospital in Gateshead. As of 1st August 2025, the contract has been awarded through a direct award process, under the Provider Selection Regime (PSR) outlined in the Health Care Services Regulations 2023.

This contract, valued at £3000, will be in effect from 1st April 2025 until 31st March 2028. It follows the completion of the intention to award notice published on 21st July 2025, with a standstill period ending on 30th July 2025. Notably, this process bypasses the typical competitive call for tender to facilitate a direct award to The Christie Pathology Partnership.

This contract provides significant opportunities for businesses involved in specialised medical laboratory services to collaborate with established healthcare providers such as the Gateshead Health NHS Foundation Trust. It represents potential growth for those who specialise in cellular pathology, particularly suppliers capable of offering the necessary clinical advice and rapid turnaround times that comply with stringent guidelines. Smaller or specialised businesses that provide laboratory services accredited by UKAS and conform to RCPath guidelines might also benefit, as these capabilities underpin the successful execution of this contract.

Such opportunities could lead to strengthened partnerships and increased visibility within the health services procurement market.